PATENT CLAIM ANALYSIS

Application Number: 15887651
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "093400"]

Abstract:
This application provides compositions, e.g., formulations, used for gastric, gastrointestinal and/or colonic treatments, and methods for making, storing and using them, including storage, including long term storage, at ambient temperature. Compositions provided herein are useful for treating various diseases or conditions such as autism spectrum disorder, Crohn's Disease, ulcerative colitis, irritable bowel syndrome, and recurrent or primary  C. difficile  infection.

Claim (Index 1):
A pharmaceutical composition comprising a fecal microbiota preparation in a lyophilized formulation comprising one or more cryoprotectants, wherein after at least 12 weeks of storage at ambient temperature, said fecal microbiota preparation is capable of maintaining at least 60% cell viability relative to the initial cell viability immediately prior to storage.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 88.0
- Lexical Diversity: 1.35714
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15155628', '15606899', '13813915', '15791868', '15782519']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.659320859931021
- 35 USC 102 Novelty (BERT): 0.5657212186496563
- Combined Prediction Score: 0.6499608958028845
- Mean Citation Score: 300.479142
- Max Citation Score: 453.92438
- Similarity Product: 381.13786501500726

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test